Torrent Pharma Q1 net up 33% to Rs 216 cr as thrust on Unichem biz pays off

Consolidated revenue up 7.5% to Rs 2,042 crore; India biz grwis 9%, US revenues up 13%

Efforts to improve its profitability, especially for that of the acquired domestic portfolio of Unichem has reaped results for the Ahmedabad-based Torrent Pharmaceuticals Ltd (TPL) in the first quarter of financial year 2019-20. The drug maker's consolidated net profit for the first quarter ended June 30, 2019 jumped 33 per cent to stand at Rs 216 crore as against Rs 163 crore for the corresponding period last year.

TPL, which is among the top five in the Indian Pharmaceuticals Market (IPM) for the therapeutics segment of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), and Vitamins Minerals Nutritionals (VMN), saw